Nexvet Biopharma Plc (NVET) Stock Price & Overview
NASDAQ:NVET
Current stock price
The current stock price of NVET is 6.72 null. Today NVET is down by 0%. In the past month the price increased by 0.75%. In the past year, price increased by 27.03%.
NVET Key Statistics
- Market Cap
- 80.102M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.75
- Dividend Yield
- N/A
NVET Stock Performance
NVET Stock Chart
NVET Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NVET. When comparing the yearly performance of all stocks, NVET is one of the better performing stocks in the market, outperforming 76.91% of all stocks.
NVET Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NVET. While NVET has a great health rating, there are worries on its profitability.
NVET Earnings
NVET Forecast & Estimates
NVET Financial Highlights
Over the last trailing twelve months NVET reported a non-GAAP Earnings per Share(EPS) of -1.75. The EPS decreased by -4.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.17% | ||
| ROA | -63.8% | ||
| ROE | -72.73% | ||
| Debt/Equity | 0 |
NVET Ownership
About NVET
Company Profile
NexvetBiopharma plc is a biopharmaceutical company. The company is focused on transforming the therapeutic market for companion animals by developing and commercializing novel biologic therapies. Its product candidate consists of NV-01, is a mAb for the control of pain associated with osteoarthritis in dogs, NV-02, is a mAb for the control of pain associated with degenerative joint disease in cats and NV-08, is a receptor fusion protein for the treatment of chronic inflammatory diseases. NexvetBiopharma plc is headquartered in Blackrock, Ireland.
Company Info
Nexvet Biopharma Plc
UNIT 5 SRAGH TECHNOLOGY PARK RAHAN ROAD
TULLAMORE L2 R35 FR98
CEO: Mark Heffernan
Phone: 353-57-932-4522
Nexvet Biopharma Plc / NVET FAQ
What does NVET do?
NexvetBiopharma plc is a biopharmaceutical company. The company is focused on transforming the therapeutic market for companion animals by developing and commercializing novel biologic therapies. Its product candidate consists of NV-01, is a mAb for the control of pain associated with osteoarthritis in dogs, NV-02, is a mAb for the control of pain associated with degenerative joint disease in cats and NV-08, is a receptor fusion protein for the treatment of chronic inflammatory diseases. NexvetBiopharma plc is headquartered in Blackrock, Ireland.
What is the stock price of Nexvet Biopharma Plc today?
The current stock price of NVET is 6.72 null.
Does Nexvet Biopharma Plc pay dividends?
NVET does not pay a dividend.
How is the ChartMill rating for Nexvet Biopharma Plc?
NVET has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is Nexvet Biopharma Plc (NVET) stock traded?
NVET stock is listed on the Nasdaq exchange.
What is the ownership structure of Nexvet Biopharma Plc (NVET)?
You can find the ownership structure of Nexvet Biopharma Plc (NVET) on the Ownership tab.